MGMT and glioma: Here we found that glioma median patient age (C1: 64.5 (± 17.4) vs C2: 47.7 (± 19.5), p > 0.05), tumor IDH status (IDHwt vs IDHmut, p > 0.05), molecular subtype (CL, MES, PN; p > 0.05), MGMT methylation status (Methylated vs unmethylated, p > 0.05) did not differ between lncRNA methylation clusters, suppl.